Orion Genomics, The Second Code Company, is an award winning biotechnology company headquartered in St. Louis, Missouri. Founded in 1998 with the goal of expanding the reach and utility of the then nascent genomics technologies, Orion Genomics has grown to a global powerhouse with strategic partnerships and collaborations in the United States, Europe and Southeast Asia.
The three divisions of Orion, Genomics Research and Services, Clinical Research and Services and Orion Biosains, are comprised of highly talented R&D scientists and bioinformaticians from around the world. These teams apply their expertise to develop alternative solutions and creative approaches to challenging issues in various industries such as human health and agriculture. With over 100 patents and patents pending, Orion Genomics has established itself as an innovator in the application and use of genetic and epigenetic technologies.